{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T01:35:07Z","timestamp":1791077707242,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T00:00:00Z","timestamp":1694476800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["W81XWH-20-1-0735"],"award-info":[{"award-number":["W81XWH-20-1-0735"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["RO1-AG031903"],"award-info":[{"award-number":["RO1-AG031903"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["P30 EY011373"],"award-info":[{"award-number":["P30 EY011373"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1EY029169"],"award-info":[{"award-number":["RO1EY029169"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000053","name":"National Eye Institute","doi-asserted-by":"publisher","award":["RO1 EY032874"],"award-info":[{"award-number":["RO1 EY032874"]}],"id":[{"id":"10.13039\/100000053","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA043703"],"award-info":[{"award-number":["P30 CA043703"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001116","name":"Foundation Fighting Blindness Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013875","name":"Challenger Society for Marine Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013875","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018576","name":"Harrington Discovery Institute, University Hospitals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000262","name":"Foundation Fighting Blindness","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000262","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.isci.2023.107916","type":"journal-article","created":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T11:36:35Z","timestamp":1694950595000},"page":"107916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Development of novel cytoprotective small compounds inhibiting mitochondria-dependent cell death"],"prefix":"10.1016","volume":"26","author":[{"given":"Mieko","family":"Matsuyama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph T.","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonah","family":"Scott-McKean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Muller-Greven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beata","family":"Jastrzebska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Greenlee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigemi","family":"Matsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2023.107916_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/s41580-018-0089-8","article-title":"Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins","volume":"20","author":"Singh","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.isci.2023.107916_bib2","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1126\/science.1059108","article-title":"Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death","volume":"292","author":"Wei","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.isci.2023.107916_bib3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/s41589-019-0306-6","article-title":"Targeting BAX to drug death directly","volume":"15","author":"Walensky","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2023.107916_bib4","doi-asserted-by":"crossref","first-page":"5276","DOI":"10.1021\/acs.jmedchem.0c02200","article-title":"Pharmacological Targeting of Executioner Proteins: Controlling Life and Death","volume":"64","author":"Pogmore","year":"2021","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib5","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.tips.2021.11.001","article-title":"Physiological and pharmacological modulation of BAX","volume":"43","author":"Spitz","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.isci.2023.107916_bib6","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41568-021-00407-4","article-title":"The manipulation of apoptosis for cancer therapy using BH3-mimetic drugs","volume":"22","author":"Diepstraten","year":"2022","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.isci.2023.107916_bib7","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1535370219833624","article-title":"Pharmacological inhibition of Bax-induced cell death: Bax-inhibiting peptides and small compounds inhibiting Bax","volume":"244","author":"Jensen","year":"2019","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.isci.2023.107916_bib8","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/nature03579","article-title":"An inhibitor of Bcl-2 family proteins induces regression of solid tumours","volume":"435","author":"Oltersdorf","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.isci.2023.107916_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrd.2016.253","article-title":"From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors","volume":"16","author":"Ashkenazi","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2023.107916_bib10","doi-asserted-by":"crossref","first-page":"4365","DOI":"10.1021\/jm034107j","article-title":"3,6-dibromocarbazole piperazine derivatives of 2-propanol as first inhibitors of cytochrome c release via Bax channel modulation","volume":"46","author":"Bombrun","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib11","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1042\/BJ20090664","article-title":"MAC inhibitors suppress mitochondrial apoptosis","volume":"423","author":"Peixoto","year":"2009","journal-title":"Biochem. J."},{"key":"10.1016\/j.isci.2023.107916_bib12","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.chembiol.2017.03.011","article-title":"A Small-Molecule Inhibitor of Bax and Bak Oligomerization Prevents Genotoxic Cell Death and Promotes Neuroprotection","volume":"24","author":"Niu","year":"2017","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2023.107916_bib13","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41589-018-0223-0","article-title":"Small-molecule allosteric inhibitors of BAX","volume":"15","author":"Garner","year":"2019","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.isci.2023.107916_bib14","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/s41467-021-21224-1","article-title":"Eltrombopag directly inhibits BAX and prevents cell death","volume":"12","author":"Spitz","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2023.107916_bib15","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1472-6750-10-81","article-title":"Improved Tet-responsive promoters with minimized background expression","volume":"10","author":"Loew","year":"2010","journal-title":"BMC Biotechnol."},{"key":"10.1016\/j.isci.2023.107916_bib16","series-title":"The Use of Novel Small Compounds of Bax Inhibitors to Protect Damaged Cells from Death","author":"Matsuyama","year":"2020"},{"key":"10.1016\/j.isci.2023.107916_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.exer.2014.04.003","article-title":"All-trans-retinal induces Bax activation via DNA damage to mediate retinal cell apoptosis","volume":"123","author":"Sawada","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.isci.2023.107916_bib18","doi-asserted-by":"crossref","first-page":"15173","DOI":"10.1074\/jbc.M900322200","article-title":"Involvement of all-trans-retinal in acute light-induced retinopathy of mice","volume":"284","author":"Maeda","year":"2009","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib19","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1124\/molpharm.120.000072","article-title":"Protective Effects of Flavonoids in Acute Models of Light-Induced Retinal Degeneration","volume":"99","author":"Ortega","year":"2021","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.isci.2023.107916_bib20","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ccr.2006.03.027","article-title":"Mitochondria primed by death signals determine cellular addiction to antiapoptotic BCL-2 family members","volume":"9","author":"Certo","year":"2006","journal-title":"Cancer Cell"},{"key":"10.1016\/j.isci.2023.107916_bib21","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/cdd.2009.48","article-title":"Different forms of cell death induced by putative BCL2 inhibitors","volume":"16","author":"Vogler","year":"2009","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2023.107916_bib22","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1073\/pnas.0808173106","article-title":"The p53-cathepsin axis cooperates with ROS to activate programmed necrotic death upon DNA damage","volume":"106","author":"Tu","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.isci.2023.107916_bib23","doi-asserted-by":"crossref","first-page":"912","DOI":"10.3389\/fphar.2019.00912","article-title":"A Novel Drug Resistance Mechanism: Genetic Loss of Xeroderma Pigmentosum Complementation Group C (XPC) Enhances Glycolysis-Mediated Drug Resistance in DLD-1 Colon Cancer Cells","volume":"10","author":"Han","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.isci.2023.107916_bib24","doi-asserted-by":"crossref","first-page":"10777","DOI":"10.1074\/jbc.273.17.10777","article-title":"Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations","volume":"273","author":"Hsu","year":"1998","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib25","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1093\/emboj\/18.9.2330","article-title":"Conformation of the Bax C-terminus regulates subcellular location and cell death","volume":"18","author":"Nechushtan","year":"1999","journal-title":"Embo J."},{"key":"10.1016\/j.isci.2023.107916_bib26","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/ncomms1093","article-title":"Protein-binding assays in biological liquids using microscale thermophoresis","volume":"1","author":"Wienken","year":"2010","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2023.107916_bib27","doi-asserted-by":"crossref","first-page":"18022","DOI":"10.1074\/jbc.M301812200","article-title":"Glucocorticoids inhibit apoptosis during fibrosarcoma development by transcriptionally activating Bcl-xL","volume":"278","author":"Gascoyne","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib28","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0006-2952(02)01147-4","article-title":"Cell-specific regulation of apoptosis by glucocorticoids: implication to their anti-inflammatory action","volume":"64","author":"Amsterdam","year":"2002","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.isci.2023.107916_bib29","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.neurol.2014.03.005","article-title":"Perspectives of drug-based neuroprotection targeting mitochondria","volume":"170","author":"Procaccio","year":"2014","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.isci.2023.107916_bib30","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","article-title":"Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing","volume":"19","author":"Cunnane","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.isci.2023.107916_bib31","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s42003-020-01584-y","article-title":"Partial inhibition of mitochondrial complex I ameliorates Alzheimer's disease pathology and cognition in APP\/PS1 female mice","volume":"4","author":"Stojakovic","year":"2021","journal-title":"Commun. Biol."},{"key":"10.1016\/j.isci.2023.107916_bib32","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.mito.2021.02.005","article-title":"A genome-wide association study in human lymphoblastoid cells supports safety of mitochondrial complex I inhibitor","volume":"58","author":"Gao","year":"2021","journal-title":"Mitochondrion"},{"key":"10.1016\/j.isci.2023.107916_bib33","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.chembiol.2018.01.011","article-title":"N-Acetyl Cysteine Functions as a Fast-Acting Antioxidant by Triggering Intracellular H2S and Sulfane Sulfur Production","volume":"25","author":"Ezerina","year":"2018","journal-title":"Cell Chem. Biol."},{"key":"10.1016\/j.isci.2023.107916_bib34","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/s43018-020-0039-1","article-title":"A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy","volume":"1","author":"Amgalan","year":"2020","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.isci.2023.107916_bib35","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.cell.2011.02.034","article-title":"Bcl-x(L) retrotranslocates Bax from the mitochondria into the cytosol","volume":"145","author":"Edlich","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.isci.2023.107916_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1038\/cdd.2012.131","article-title":"The C-terminal helix of Bcl-x(L) mediates Bax retrotranslocation from the mitochondria","volume":"20","author":"Todt","year":"2013","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.isci.2023.107916_bib37","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nbt.1606","article-title":"Nutrient-sensitized screening for drugs that shift energy metabolism from mitochondrial respiration to glycolysis","volume":"28","author":"Gohil","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2023.107916_bib38","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.1021\/acs.jmedchem.8b00278","article-title":"Discovery of Novel 1,3,8-Triazaspiro[4.5]decane Derivatives That Target the c Subunit of F1\/FO-Adenosine Triphosphate (ATP) Synthase for the Treatment of Reperfusion Damage in Myocardial Infarction","volume":"61","author":"Morciano","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib39","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1128\/MMBR.00016-08","article-title":"ATP synthase and the actions of inhibitors utilized to study its roles in human health, disease, and other scientific areas","volume":"72","author":"Hong","year":"2008","journal-title":"Microbiol. Mol. Biol. Rev."},{"key":"10.1016\/j.isci.2023.107916_bib40","doi-asserted-by":"crossref","first-page":"4684","DOI":"10.2174\/092986711797379177","article-title":"Targeting the F1Fo ATP Synthase: modulation of the body's powerhouse and its implications for human disease","volume":"18","author":"Johnson","year":"2011","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib41","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1755-5922.2008.00065.x","article-title":"Pharmacological profile of the selective mitochondrial F1F0 ATP hydrolase inhibitor BMS-199264 in myocardial ischemia","volume":"26","author":"Grover","year":"2008","journal-title":"Cardiovasc. Ther."},{"key":"10.1016\/j.isci.2023.107916_bib42","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/S1097-2765(00)80033-7","article-title":"The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells","volume":"1","author":"Matsuyama","year":"1998","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2023.107916_bib43","doi-asserted-by":"crossref","first-page":"3051","DOI":"10.1523\/JNEUROSCI.5620-07.2008","article-title":"Lack of pathology in a triple transgenic mouse model of Alzheimer's disease after overexpression of the anti-apoptotic protein Bcl-2","volume":"28","author":"Rohn","year":"2008","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.isci.2023.107916_bib44","doi-asserted-by":"crossref","first-page":"8161","DOI":"10.1073\/pnas.0609874104","article-title":"Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease","volume":"104","author":"Perier","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.107916_bib45","doi-asserted-by":"crossref","first-page":"8774","DOI":"10.1523\/JNEUROSCI.2315-06.2006","article-title":"Complete dissociation of motor neuron death from motor dysfunction by Bax deletion in a mouse model of ALS","volume":"26","author":"Gould","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.isci.2023.107916_bib46","doi-asserted-by":"crossref","first-page":"12849","DOI":"10.1523\/JNEUROSCI.4086-06.2006","article-title":"Neuromuscular denervation: Bax up against the wall in amyotrophic lateral sclerosis","volume":"26","author":"Steele","year":"2006","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.isci.2023.107916_bib47","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1172\/JCI42986","article-title":"Blocking the mitochondrial apoptotic pathway preserves motor neuron viability and function in a mouse model of amyotrophic lateral sclerosis","volume":"120","author":"Reyes","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2023.107916_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0278-5846(03)00021-6","article-title":"Apoptosis in Huntington's disease","volume":"27","author":"Hickey","year":"2003","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.isci.2023.107916_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1007\/BF03401871","article-title":"BAX contributes to apoptotic-like death following neonatal hypoxia-ischemia: evidence for distinct apoptosis pathways","volume":"7","author":"Gibson","year":"2001","journal-title":"Mol. Med."},{"key":"10.1016\/j.isci.2023.107916_bib50","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/cc2950","article-title":"Bench-to-bedside review: Apoptosis\/programmed cell death triggered by traumatic brain injury","volume":"9","author":"Zhang","year":"2005","journal-title":"Crit. Care"},{"key":"10.1016\/j.isci.2023.107916_bib51","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1089\/neu.2000.17.927","article-title":"Apoptosis after traumatic brain injury","volume":"17","author":"Raghupathi","year":"2000","journal-title":"J.\u00a0Neurotrauma"},{"key":"10.1016\/j.isci.2023.107916_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2017.01.002","article-title":"BAX to basics: How the BCL2 gene family controls the death of retinal ganglion cells","volume":"57","author":"Maes","year":"2017","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.isci.2023.107916_bib53","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1007\/s12035-019-01783-7","article-title":"BAX-Depleted Retinal Ganglion Cells Survive and Become Quiescent Following Optic Nerve Damage","volume":"57","author":"Donahue","year":"2020","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.isci.2023.107916_bib54","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/s41419-021-04068-x","article-title":"BCLX(L) gene therapy moderates neuropathology in the DBA\/2J mouse model of inherited glaucoma","volume":"12","author":"Donahue","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.isci.2023.107916_bib55","doi-asserted-by":"crossref","first-page":"26684","DOI":"10.1074\/jbc.M804505200","article-title":"Retinopathy in mice induced by disrupted all-trans-retinal clearance","volume":"283","author":"Maeda","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib56","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1124\/mol.118.112581","article-title":"Protective Effect of a Locked Retinal Chromophore Analog against Light-Induced Retinal Degeneration","volume":"94","author":"Gao","year":"2018","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.isci.2023.107916_bib57","doi-asserted-by":"crossref","first-page":"11668","DOI":"10.1073\/pnas.0403499101","article-title":"Rpe65 Leu450Met variant is associated with reduced levels of the retinal pigment epithelium lipofuscin fluorophores A2E and iso-A2E","volume":"101","author":"Kim","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2023.107916_bib58","doi-asserted-by":"crossref","first-page":"5059","DOI":"10.1074\/jbc.M111.315432","article-title":"Mechanism of all-trans-retinal toxicity with implications for stargardt disease and age-related macular degeneration","volume":"287","author":"Chen","year":"2012","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.isci.2023.107916_bib59","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/cdd.2009.6","article-title":"Hdm2 is a ubiquitin ligase of Ku70-Akt promotes cell survival by inhibiting Hdm2-dependent Ku70 destabilization","volume":"16","author":"Gama","year":"2009","journal-title":"Cell Death Differ."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223019934?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004223019934?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:28:54Z","timestamp":1762630134000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004223019934"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":59,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2589004223019934"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2023.107916","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of novel cytoprotective small compounds inhibiting mitochondria-dependent cell death","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2023.107916","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"107916"}}